WCM Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-285,665	Closed	-$5.27M	–	319
2024 Q3	$5.27M	Sell	285,665 -7,236	-2%	-$148K	0.01%	166
2024 Q2	$6.28M	Sell	292,901 -4,757	-2%	-$109K	0.01%	156
2024 Q1	$8.02M	Buy	297,658 +1,645	+0.6%	+$46.7K	0.02%	148
2023 Q4	$9.15M	Buy	296,013 +7,212	+2%	+$159K	0.03%	144
2023 Q3	$5.89M	Buy	288,801 +5,867	+2%	+$107K	0.02%	147
2023 Q2	$5.62M	Buy	282,934 +29,123	+11%	+$588K	0.02%	151
2023 Q1	$4.35M	Buy	253,811 +2,113	+0.8%	+$41.4K	0.01%	159
2022 Q4	$4.93M	Sell	251,698 -139,232	-36%	-$2.56M	0.02%	160
2022 Q3	$5.49M	Buy	390,930 +20,181	+5%	+$315K	0.02%	147
2022 Q2	$4.83M	Buy	370,749 +163,575	+79%	+$1.95M	0.02%	149
2022 Q1	$3.29M	Buy	207,174 +14,245	+7%	+$246K	0.01%	155
2021 Q4	$4.21M	Buy	192,929 +95,664	+98%	+$2.61M	0.01%	156
2021 Q3	$2.91M	Buy	97,265 +464	+0.5%	+$16.9K	0.01%	162
2021 Q2	$4.29M	Buy	96,801 +3,811	+4%	+$166K	0.01%	141
2021 Q1	$4.13M	Sell	92,990 -2,145	-2%	-$118K	0.01%	141
2020 Q4	$5.22M	Buy	+95,135	New	+$3.47M	0.01%	143